Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
August 7, 2019
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
L Nogueras, H Gonzalo, M Jové, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
BMC Health Services Research
|
January 19, 2017
COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study
Julie E Potter, Robert G Herkes, Lin Perry, et al.
Archives of Neurology
|
February 15, 2001
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients
J Honnorat, A Saiz, B Giometto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
L Grau-López, A Teniente-Serra, M Tintoré, et al.
Neurology
|
August 12, 2004
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial
J Río, C Nos, I Bonaventura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Neurologia
|
September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
L Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Neurologia
|
June 21, 2020
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
S Otero-Romero, J Rodríguez-García, A Vilella, et al.
Revista De Neurologia
|
June 27, 2024
[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)]
O Fernández, X Montalbán, E Agüera, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
August 7, 2019
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
L Nogueras, H Gonzalo, M Jové, et al.
European Journal of Neurology
|
October 24, 2018
Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double-blind, non-inferiority trial
J V Hervás-García, L Ramió-Torrentà, L Brieva-Ruiz, et al.
BMC Health Services Research
|
January 19, 2017
COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study
Julie E Potter, Robert G Herkes, Lin Perry, et al.
Archives of Neurology
|
February 15, 2001
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients
J Honnorat, A Saiz, B Giometto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses
L Grau-López, A Teniente-Serra, M Tintoré, et al.
Neurology
|
August 12, 2004
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial
J Río, C Nos, I Bonaventura, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Neurologia
|
September 5, 2022
Gadolinium-enhanced brain lesions in multiple sclerosis relapse
L Martín-Aguilar, S Presas-Rodriguez, À Rovira, et al.
Neurologia
|
June 21, 2020
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
S Otero-Romero, J Rodríguez-García, A Vilella, et al.
Revista De Neurologia
|
June 27, 2024
[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023 ECTRIMS Congress (I)]
O Fernández, X Montalbán, E Agüera, et al.
Page
of 6